| |
Latest 10 SEC filings (by transaction date) for VTYX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 16/24 | Apr 12/24 | Subramaniam Somu | Indirect Ownership | Common Stock | J - Other transaction | -695,339 | |
Apr 16/24 | Apr 12/24 | NSV Partners III LP | Indirect Ownership | Common Stock | J - Other transaction | -695,339 | |
Apr 3/24 | Apr 2/24 | Krueger Christopher W | Direct Ownership | Common Stock | S - Open market or private sale | -1,651 | $5.40 |
Apr 3/24 | Apr 2/24 | Nuss John | Direct Ownership | Common Stock | S - Open market or private sale | -1,651 | $5.40 |
Apr 3/24 | Apr 2/24 | Mohan Raju | Direct Ownership | Common Stock | S - Open market or private sale | -4,312 | $5.40 |
Apr 3/24 | Apr 2/24 | Auster Martin | Direct Ownership | Common Stock | S - Open market or private sale | -1,405 | $5.40 |
Mar 29/24 | Mar 28/24 | Krueger Christopher W | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -4,531 | |
Mar 29/24 | Mar 28/24 | Krueger Christopher W | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,531 | |
Mar 29/24 | Mar 28/24 | Auster Martin | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -4,531 | |
Mar 29/24 | Mar 28/24 | Auster Martin | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,531 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for VTYX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 16/24 | Apr 12/24 | Subramaniam Somu | Indirect Ownership | Common Stock | J - Other transaction | -695,339 | |
Apr 16/24 | Apr 12/24 | NSV Partners III LP | Indirect Ownership | Common Stock | J - Other transaction | -695,339 | |
Apr 3/24 | Apr 2/24 | Krueger Christopher W | Direct Ownership | Common Stock | S - Open market or private sale | -1,651 | $5.40 |
Apr 3/24 | Apr 2/24 | Nuss John | Direct Ownership | Common Stock | S - Open market or private sale | -1,651 | $5.40 |
Apr 3/24 | Apr 2/24 | Mohan Raju | Direct Ownership | Common Stock | S - Open market or private sale | -4,312 | $5.40 |
Apr 3/24 | Apr 2/24 | Auster Martin | Direct Ownership | Common Stock | S - Open market or private sale | -1,405 | $5.40 |
Mar 29/24 | Mar 28/24 | Krueger Christopher W | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -4,531 | |
Mar 29/24 | Mar 28/24 | Krueger Christopher W | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,531 | |
Mar 29/24 | Mar 28/24 | Auster Martin | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -4,531 | |
Mar 29/24 | Mar 28/24 | Auster Martin | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,531 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |